4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-23-003457
Options or other derivatives
- Chairman and CEO acquired 7,500,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Niihara Yutaka Chairman and CEO | 2023-01-12 | Grant or award · Warrants (right to buy) | +7,500,000 | $4.50 | $33,750,000 | 0 | D |
Loading xslF345X03/doc4.xml…